Clinical Trial

Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors

Name: Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors — clinical trial record (NCT07207681)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KXV01 TCR Lentinvivo for patients with advanced solid tumors.

Trial Details

NCT Number	NCT07207681
Lead Sponsor	The First Hospital of Jilin University
Conditions	Advanced Solid Tumors
Enrollment	30 participants
Start Date	2025-10-15
Primary Completion	2026-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-10-06